Manufacture

RNA sequence design is emerging as a path to transform the economics and methodologies of RNA as a drug modality.

Why cell and gene therapy manufacturing has a lot to learn from the automotive sector.

Experts discuss the trends, challenges, and possibilities of cryopreservation for cell and gene – and how it can freeze time in manufacturing.

Sitting Down With … Piper Trelstad, Head of CMC, The Bill & Melinda Gates Medical Research Institute

Experts from Lonza share how biologics and CGT can recognize the gaps and similarities that can be utilized to optimize cell culture media challenges.

The latest X-ray technology goes beyond foreign body detection, ensuring each dose is right first time – every time.

Anna Codina from Bruker BioSpin discusses the Biosecure Act and how outsourcing could be affected.

How whole genome sequencing is being used to understand the bacterium that causes syphilis – and what it means for vaccine development.

The Alliance for RTU has been founded to accelerate and improve manufacturing quality, consistency, and regulatory efficiency.

Why the traditional model of drug development is no longer fit for purpose.